DR REDDY'S Files Routine 6-K on March 26, 2026
Ticker: RDY · Form: 6-K · Filed: Mar 26, 2026 · CIK: 0001135951
Complexity: simple
Sentiment: neutral
Topics: compliance, foreign-issuer, routine-filing
TL;DR
**DR REDDY'S filed a routine 6-K, nothing new to see here.**
AI Summary
DR REDDY'S LABORATORIES LTD filed a 6-K on March 26, 2026, indicating a routine report for foreign issuers. This filing, with accession number 0001575872-26-000166, includes the main 6-K document and an Exhibit 99.1. For investors, this filing is a standard update and doesn't contain new material financial or operational news, meaning it likely won't cause significant stock price movement.
Why It Matters
This is a standard compliance filing for foreign companies and does not contain new, market-moving information, so investors should not expect any immediate impact on the stock.
Risk Assessment
Risk Level: low — This 6-K filing is a standard report and does not disclose any new risks or material changes to the company's operations or financials.
Analyst Insight
Investors should recognize this as a routine compliance filing without new material information, suggesting no immediate action is required based solely on this report.
Key Numbers
- 2026-03-26 — Filing Date (The date the 6-K was filed and accepted by the SEC.)
- 4 — Number of Documents (The total number of documents included in the filing.)
- 001-15182 — File No. (The SEC file number for DR REDDYS LABORATORIES LTD.)
Key Players & Entities
- DR REDDYS LABORATORIES LTD (company) — the filer of the 6-K
- 0001135951 (company) — CIK of DR REDDYS LABORATORIES LTD
- 0001575872-26-000166 (dollar_amount) — SEC Accession No. for the filing
Forward-Looking Statements
- The stock price of DR REDDY'S LABORATORIES LTD will remain stable following this filing. (DR REDDYS LABORATORIES LTD) — high confidence, target: 2026-03-27
FAQ
What is the purpose of a 6-K filing for DR REDDY'S LABORATORIES LTD?
A 6-K is a 'Report of foreign issuer' filed under Rules 13a-16 and 15d-16, used by foreign private issuers to report material information to the SEC that is made public in their home country or filed with a foreign stock exchange.
When was this specific 6-K filing submitted and accepted by the SEC?
This 6-K filing was submitted and accepted on March 26, 2026, at 07:18:41.
What is the SEC Accession Number for this filing?
The SEC Accession Number for this filing is 0001575872-26-000166.
How many documents are included in this 6-K submission?
There are 4 documents included in this submission, specifically a FORM 6-K (rdy0866_6k.htm), an EXHIBIT 99.1 (rdy0866_ex99-1.htm), and two graphic files (rdy0866_ex99-1img01.jpg and rdy0866_ex99-1img02.jpg).
What is the CIK and SIC code for DR REDDYS LABORATORIES LTD as per this filing?
The CIK for DR REDDYS LABORATORIES LTD is 0001135951, and its SIC code is 2834, which corresponds to 'Pharmaceutical Preparations'.
Filing Stats: 400 words · 2 min read · ~1 pages · Grade level 16.3 · Accepted 2026-03-26 07:18:41
Filing Documents
- rdy0866_6k.htm (6-K) — 42KB
- rdy0866_ex99-1.htm (EX-99.1) — 66KB
- rdy0866_ex99-1img01.jpg (GRAPHIC) — 10KB
- rdy0866_ex99-1img02.jpg (GRAPHIC) — 10KB
- 0001575872-26-000166.txt ( ) — 136KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. DR. REDDY'S LABORATORIES LIMITED (Registrant) Date: March 26, 2026 By: /s/ K Randhir Singh Name: K Randhir Singh Title: Company Secretary 3